Pradipsinh Rathod at the University of Washington has received a Grand Challenges Explorations Phase II grant to continue working on strategies to disable the hypermutation exhibited by malaria parasites confronted with antimalarial drugs. Learn more about his research into improving the efficacy of new and existing drug therapies and the next steps in his Explorations project.
